Fortress Biotech Inc. Common Stock (FBIO)
Stock · NASDAQ · Health Care
$2.77as of 8/28/2026
Price chart
Open in TradingViewActive signals
About FBIO
Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for the treatment of axillary hyperhidrosis; Accutane, an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne;…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 78
- Website
- www.fortressbiotech.com/
Fundamentals
- 1-day range
- $2.75$2.81
- Market cap
- $92.02M
- P/E (trailing)
- 0.75
- P/E (forward)
- -1.57
- EPS (trailing)
- $3.44
- Dividend yield
- —
- Beta
- 1.20
- Avg. volume
- 613.5K
How Fortress Biotech Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 31, 2026 · via SEC EDGAR / Finnhub
Forecasts
2 analyst ratings
Fortress Biotech Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- FBIOFortress Biotech Inc. Common Stock$2.77▼ 1.07%Market cap $92.02MP/E 0.75$2.18$4.53
- VRCAVerrica Pharmaceuticals Inc. Common Stock$5.54▲ 9.27%Market cap $92.08MP/E —$3.28$9.82
- NTHINeOnc Technologies Holdings Inc. Common Stock$4.69▲ 1.74%Market cap $90.77MP/E —$3.01$12.99
- ONCYOncolytics Biotech Inc. Common Stock$0.8457▼ 0.51%Market cap $95.55MP/E —$1.39$1.44
- ALDXAldeyra Therapeutics Inc. Common Stock$1.49▼ 3.57%Market cap $95.91MP/E —$1.07$6.18
- RANIRani Therapeutics Holdings Inc. Class A Common Stock$0.845▼ 1.05%Market cap $96.76MP/E —$0.44$3.87
- MAIAMAIA Biotechnology Inc. Common Stock$1.33▼ 3.99%Market cap $86.34MP/E —$0.87$3.19
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| FBIO Fortress Biotech Inc. Common Stock | $92.02M | 0.75 | $2.77 | ▼ 1.07% | $2.18$4.53 |
| VRCA Verrica Pharmaceuticals Inc. Common Stock | $92.08M | — | $5.54 | ▲ 9.27% | $3.28$9.82 |
| NTHI NeOnc Technologies Holdings Inc. Common Stock | $90.77M | — | $4.69 | ▲ 1.74% | $3.01$12.99 |
| ONCY Oncolytics Biotech Inc. Common Stock | $95.55M | — | $0.8457 | ▼ 0.51% | $1.39$1.44 |
| ALDX Aldeyra Therapeutics Inc. Common Stock | $95.91M | — | $1.49 | ▼ 3.57% | $1.07$6.18 |
| RANI Rani Therapeutics Holdings Inc. Class A Common Stock | $96.76M | — | $0.845 | ▼ 1.05% | $0.44$3.87 |
| MAIA MAIA Biotechnology Inc. Common Stock | $86.34M | — | $1.33 | ▼ 3.99% | $0.87$3.19 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Fortress Biotech, Inc. Q2 2026 Earnings Call SummaryYahoo · 8/14/2026
- Fortress Biotech (FBIO) Q2 2026 Earnings Call TranscriptYahoo · 8/14/2026
- Fortress Biotech Q2 EPS $(0.08) Beats $(0.20) Estimate, Sales $18.718M Beat $18.300M Estimatebenzinga · 8/13/2026
- Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate HighlightsYahoo · 8/13/2026
- Fortress Biotech, Inc. (FBIO) Q2 2026 Earnings Call TranscriptSeekingAlpha · 8/13/2026
- Fortress Biotech Q2 Earnings Call HighlightsYahoo · 8/12/2026
- Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate HighlightsYahoo · 8/12/2026
- Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026Yahoo · 8/5/2026
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga · 8/3/2026
Insider Activity
Insider Actions →- David Jin · June 22, 2026 · Grant400.0K
- David Jin · April 1, 2026 · Grant3.0K @ $2.18
- Lindsay A. Rosenwald, MD · March 18, 2026 · Grant475.4K
- Michael S. Weiss · March 18, 2026 · Grant475.4K
Institutional Ownership
March 31, 2026
- Total shares held
- 5.57M
- Total value held
- $13.84M
- Institutional holders
- 49
- Unknown1.04M
- Unknown966.0K
- Unknown506.6K
- Unknown305.5K
- Unknown290.3K
- Unknown254.1K
- Unknown230.1K
- Unknown209.4K
- Unknown197.1K
- Unknown196.8K
See the full, filterable feed with live charts on the MarketWall dashboard.